Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

Lancet

Volumn 349, Issue 9065, 1997, Pages 1594-1597

  Pérez, Victor ^a   Gilaberte, Inmaculada ^b   Faries, Douglas ^c   Alvarez, Enric ^a   Artigas, Francesc ^d  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b ELI LILLY AND COMPANY   (Spain)

^c Lilly USA   (United States)

^d CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTORECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUOXETINE; PINDOLOL; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0342894667     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)08007-5     Document Type: Article

References (29)

1. Judd LL. Mood disorders in the general population represent an important and worldwide public health problem. Int Clin Psychopharmacol 1995; 10 (suppl4): 5-10.
2. Rudorfer MV, Potter WZ. Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the "newer" versus the "older" drugs. Drugs 1989; 37: 713-38.
3. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 1994; 114: 559-65.
4. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994; 9 (suppl): 19-26.
5. Bel N, Artigas F. Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats. J Neurochem 1996; 67: 669-76.
6. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 1990; 47: 411-18.
7. Adell A, Artigas F. Differential effects of clomipramine given locally or systematically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 1991; 343: 237-44.
8. Artigas F. 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol Sci 1993; 14: 262.
9. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994; 51: 248-51.
10. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995; 15: 217-22.
11. Stassen HH, Delini-Stula A, Angst J. Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur Neuropsychopharmacol 1993; 3: 127-35.
12. Norman TR, Leonard BE. Fast-acting antidepressants - can the need be met? CNS Drugs 1994; 2: 120-31.
13. Laska EM, Siegel C. Characterising onset in psychopharmacological clinical trials. Psychopharmacol Bull 1995; 31: 29-35.
14. Montgomery SA. Are 2-week trials sufficient to indicate efficacy? Psychopharmacol Bull 1995; 31: 41-44.
15. Overall JE. Justifying a "fast acting" claim for antidepressant drugs. Psychopharmacol Bull 1995; 31: 45-55.
16. Lee ET. Statistical methods for survival data analysis, 2nd ed. New York: Wiley, 1992.
17. Peace KE.The alternative hypothesis: one-sided or two-sided? J Clin Epidemiol 1989; 42: 472-76.
18. Browner WS, Newman TB, Cummings SR, Hully SR. Getting ready to estimate sample size: hypotheses and underlying principles. In: Hulley SB, Cummings SR, eds. Designing clinical research. Baltimore: Williams and Wilkins, 1988; 128-38.
19. Koch CG. One-sided and two-sided tests and p values. J Biopharm Stat 1991; 1: 161-70.
20. Tollefson GD, Holman SL, Sayler ME, Potvin JH. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 1994; 55: 50-59.
21. Tollefson GD, Holman SL. How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxotine or placebo. Int Clin Psychopharmacol 1994; 9: 245-50.
22. Rothschild R, Quitkin FM. Review of the use of pattern analysis to differentiate true drug and placebo responses. Psychother Psychosom 1992; 58: 170-77.
23. Martindale. The extra pharmacopoeia. London:The Pharmaceutical Press, 1993.
24. Bailly D. The role of beta-adrenoceptor blockers in the treatment of psychiatric disorders. CNS Drugs 1996; 5: 115-36.
25. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986; 255: 357-60.
26. Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 1980; 210: 88-90.
27. Palvimaki EP, Laakso A, Kuoppamaki M, et al. Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology (Berl) 1994; 115: 543-46.
28. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 1996; 15: 349-60.
29. 1A receptors. Neurochem Res 1996; 21: 557-62.